Sublingual immunotherapy (SLIT) vs subcutaneous immunotherapy (SCIT)

Sublingual immunotherapy (SLIT) is gaining acceptance in otolaryngology circles, but is it really any better than subcutaneous injections? Which patients can benefit from it? How can it affect practice?

These are questions ENT Today set out to answer by asking three physicians who use SLIT in practice: Bradley F. Marple, MD, Professor of Otolaryngology at University of Texas Southwestern Medical School; Mary Morris, MD, an allergist and partner at Allergy Associates of La Crosse, and Medical Director for Allergy Choices in Wisconsin; and Steven B. Levine, MD, Assistant Clinical Professor of Otolaryngology at Yale University.
http://www.entoday.com/pt/re/entoday/fulltext.01265117-200902000-00008.htm;jsessionid=JhTWS5gTNn4PdG2TZ49QNB84FkkxXlGJkHYxrdqmMHW7LLHvlVC9!-858031623!181195628!8091!-1